Research & Grant Opportunities

+ About Dr. Francis Glorieux

Dr. Francis H. Glorieux received his MD from the University of Louvain and his PhD from McGill University. It is there that he developed his interest in heritable pediatric bone diseases. His doctoral thesis demonstrated that calcitriol and phosphate allowed for control of the bone disease in hypophosphatemic rickets. This regimen is still used worldwide in such patients. He also demonstrated the beneficial effects of bisphosphonate in severe forms of Osteogenesis Imperfecta. Programs based on the Montreal protocols are now used all over the world. From 1973 to 2011, he was the Head of the Genetics Unit at the Montreal Shriners Hospital for Children and a Professor at McGill University. He is now Emeritus Director of Research at the Shriners Hospital and Emeritus Professor of Surgery, Pediatrics and Human Genetics at McGill. Since 2009, he has been the Chair of the Medical Advisory Council of the Osteogenesis Imperfecta Foundation (USA). He has published more than 315 peer-reviewed papers, and co-edited 3 books. He is the recipient of both the Bartter and the Neuman Awards of the American Society for Bone and Mineral Research (ASBMR). He holds honorary doctoral degrees from the Universities of Amiens and Lyons (France). In 2004, Dr Glorieux was made an Officer of the Order of Canada, the country’s highest honor for lifetime achievement.]

+ About the COIS Research Fellowship Program

The COIS Research Fellowship is open to individuals in a postgraduate or doctorate level of study. Fellowships will be awarded to candidates whose research application is deemed to offer a potentially critical contribution to OI research and treatment. Fellowships may be awarded for one- or two-year periods depending on the proposed area of study.

+ Application process

Applications for the Francis Glorieux Research Fellowship will be open to applicants in the fall of 2021 with selections made by Jan 1, 2022 and grants awarded for work to commence in 2022.

Further details will be posted in September 2021.